Related Experiment Video
Updated: Mar 1, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Controlling the family-wise error rate in multi-arm, multi-stage trials
Luis A Crouch1, Lori E Dodd2, Michael A Proschan2
11 Department of Biostatistics, University of Washington, Seattle, WA, USA.
Multi-arm, multi-stage trials can improve clinical trial efficiency. This study introduces a simple design that controls the family-wise error rate, reducing sample size without sacrificing statistical power.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Drug Development
Background:
- Multi-arm, multi-stage (MAMS) trials are gaining traction for enhanced clinical trial efficiency.
- Existing MAMS designs often overlook multiplicity issues, leading to type I error rate inflation.
- A need exists for efficient MAMS designs that rigorously control statistical error rates.
Purpose of the Study:
- To propose a straightforward MAMS trial design.
- To control the family-wise error rate (FWER) in MAMS trials.
- To improve trial efficiency, measured by reduced sample size and time.
Main Methods:
- Developed an analytical method to calculate FWER for MAMS trials.
- Proposed a novel MAMS design to control FWER.
- Included methods for computing statistical power and expected sample size.
Main Results:
- The proposed method effectively controls FWER across various MAMS designs.
- The design significantly reduces the expected sample size compared to uncontrolled designs.
- Adequate statistical power is maintained while controlling the error rate.
Conclusions:
- MAMS designs offer substantial reductions in clinical trial time and resources.
- The proposed simple design achieves efficiency gains while controlling FWER.
- This approach minimizes power loss, making it a practical option for trial optimization.
Related Concept Videos
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
Systematic Error: Methodological and Sampling Errors
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
Random and Systematic Errors
Bonferroni Test
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Propagation of Uncertainty from Systematic Error

